Evidence map›Paper›PMID 36927593›Full record

ArticleBMJ open2023

Categorising implementation determinants and strategies within the US HIV implementation literature: a systematic review protocol.

James Lorenz Merle, Dennis Li, Brennan Keiser, Alithia Zamantakis, Artur Queiroz, Carlos G Gallo, Juan A Villamar, Virginia McKay, Juan Pablo Zapata, Brian Mustanski and 2 more

Open access · goldAbstract read
In one paragraph

Article in BMJ open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
6.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

James Lorenz MerleDepartment of Population Health Sciences, University of Utah Health, Salt Lake City, Utah, USA james.merle@utah.edu.ORCID 0000-0001-9646-2733
Dennis LiDepartment of Psychiatry and Behavioral Sciences, Northwestern University, Evanston, Illinois, USA.
Brennan KeiserDepartment of Medical Social Sciences, Northwestern University, Chicago, Illinois, USA.
Alithia ZamantakisDepartment of Medical Social Sciences, Northwestern University, Chicago, Illinois, USA.
Artur QueirozDepartment of Medical Social Sciences, Northwestern University, Chicago, Illinois, USA.
Carlos G GalloDepartment of Psychiatry and Behavioral Sciences, Northwestern University, Evanston, Illinois, USA.
Juan A VillamarDepartment of Psychiatry and Behavioral Sciences, Northwestern University, Evanston, Illinois, USA.
Virginia McKayCenter for Public Health Systems Science, Brown School, Washington University in St. Louis, St Louis, Missouri, USA.ORCID 0000-0002-9299-3294
Juan Pablo ZapataDepartment of Medical Social Sciences, Northwestern University, Chicago, Illinois, USA.ORCID 0000-0002-1996-6863
Brian MustanskiDepartment of Medical Social Sciences, Northwestern University, Chicago, Illinois, USA.
Nanette BenbowDepartment of Psychiatry and Behavioral Sciences, Northwestern University, Evanston, Illinois, USA.
Justin D SmithDepartment of Population Health Sciences, University of Utah Health, Salt Lake City, Utah, USA.ORCID 0000-0003-3264-8082
Northwestern University · USUniversity of Utah · USWashington University in St. Louis · US

Funding

Virology and Immunology Technology CoreP30AI117943 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Mohamed Abdel Mohsen · 2015 to 2026
$38.4M
UNIVERSITY OF UTAH MEDICAL INFORMATICS TRAININGT15LM007124 · NLM · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Karen Louise Eilbeck · 1997 to 2026
$22.0M
Training Program in Translational Science, HIV, and Sexual and Gender Minority HealthT32MH130325 · NIMH · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Michael E Newcomb · 2022 to 2026
$1.6M
NCATS NIH HHS L30 TR004276NIAID NIH HHS P30 AI117943NIMH NIH HHS T32 MH130325NLM NIH HHS T15 LM007124
6 · The paper itself

Abstract

introductionDespite decreased rates of new infections, HIV/AIDS continues to impact certain US populations. In order to achieve the goals laid out in the Ending the HIV Epidemic (EHE) in the US initiative, implementation science is needed to expand the sustained use of effective prevention and treatment interventions, particularly among priority populations at risk for and living with HIV/AIDS. Over 200 HIV-related implementation studies have been funded by the US National Institutes of Health. Therefore, a comprehensive review of the literature identifying implementation determinants (barriers and facilitators) and categorising implementation strategies across the continuum of HIV prevention and care in the USA is appropriate and needed to enhance current knowledge and help achieve the goals laid out in the EHE national strategic plan. METHODS AND ANALYSIS: This systematic review protocol follows the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Between November 2020 and January 2022, a broad database search strategy of Ovid MEDLINE, PsycINFO and Web of Science was conducted to capture implementation-related studies along the HIV prevention and care continuum. Articles were eligible for inclusion if they were: conducted in the USA, published after the year 2000, written in English, related to HIV/AIDS, focused on outcomes related to dissemination and implementation (ie, did not test/evaluate/explore implementation determinants or strategies) and were behavioural studies (ie, not basic science). We plan to conduct three systematic reviews to identify and categorise determinants and strategies associated with three HIV focus areas: pre-exposure prophylaxis, testing/diagnosing and linkage to care, and treatment. Determinants will be coded according to an adapted Consolidated Framework for Implementation Research 2.0. Implementation strategies and outcomes will be categorised in accordance with existing taxonomies and frameworks. ETHICS AND DISSEMINATION: Ethics approval is not applicable. No original data will be collected. Results will be disseminated through peer-reviewed publications, conference presentations and via online tools. PROSPERO REGISTRATION NUMBER: CRD42021233089.

Indexed as

Acquired Immunodeficiency SyndromeEpidemicsHumansSystematic Reviews as TopicUnited StatesHIV & AIDSPREVENTIVE MEDICINEProtocols & guidelines

Identifiers

PMID36927593
PMCPMC10030793
OpenAlexW4327627007

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.